METOPROLOL-L 100 MG — DIN 02315122
METOPROLOL TARTRATE : 100 MG · SORRES PHARMA INC · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is METOPROLOL-L?
METOPROLOL-L 100 MG contains METOPROLOL TARTRATE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02315122, held by SORRES PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 20-Jun-2014. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
What is METOPROLOL-L used for?
Mild or moderate hypertension; long-term treatment of angina pectoris; treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce mortality.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Metoprolol cost around the world?
Metoprolol is listed on 3 of the national price registers Nexara ingests. Each country publishes on a different basis, so figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Austria publishes a KVP (Kassenverkaufspreis); Czechia publishes a max producer price (ex-factory); Luxembourg publishes a reimbursement. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed |
|---|---|---|---|
| Czechia | max producer price (ex-factory) | 7 | 31 |
| Austria | KVP (Kassenverkaufspreis) | 12 | 24 |
| Luxembourg | reimbursement | 2 | 2 |
57 pack listings across 21 brand entries and 3 price bases, refreshed 05 Sep 2026. Ranges span every Metoprolol pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Metoprolol in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
28 holders have a Canadian DIN containing Metoprolol, across 103 DINs, of which 30 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 9 | 5 | NTP-METOPROLOL, TEVA-METOPROLOL | Sourceable in Canada |
| APOTEX INC | 5 | 5 | APO-METOPROLOL, APO-METOPROLOL (TYPE L) | Sourceable in Canada |
| PRO DOC LIMITEE | 8 | 3 | METOPROLOL SR, PRO-METOPROLOL, PRO-METOPROLOL-L | Sourceable in Canada |
| PHARMASCIENCE INC | 7 | 3 | PMS-METOPROLOL-B TABLETS - 100MG, PMS-METOPROLOL-B TABLETS - 50MG, PMS-METOPROLOL-L, PMS-METOPROLOL-L SR | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 3 | 3 | JAMP-METOPROLOL-L | Sourceable in Canada |
| LABORATOIRE RIVA INC. | 3 | 3 | RIVA-METOPROLOL-L | Sourceable in Canada |
| SIVEM PHARMACEUTICALS ULC | 3 | 3 | METOPROLOL-L | Sourceable in Canada |
| SANIS HEALTH INC | 2 | 2 | METOPROLOL | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 7 | 1 | METOPROLOL TARTRATE INJECTION USP, SANDOZ METOPROLOL (TYPE L), SANDOZ METOPROLOL SR | Sourceable in Canada |
| AA PHARMA INC | 2 | 1 | AA-METOPROLOL SR | Sourceable in Canada |
| JUNO PHARMACEUTICALS CORP. | 1 | 1 | METOPROLOL TARTRATE INJECTION USP | Sourceable in Canada |
| NU-PHARM INC | 9 | 0 | NU-METOP TAB 100MG, NU-METOP TAB 50MG, NU-METOPROLOL, NU-METOPROLOL (TYPE L), NU-METOPROLOL SR | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | Not explicitly detailed in provided text (mentions 25 mg, 50 mg, and 100 mg strengths). |
| Storage | Store at 15-30°C (implied by standard USP/Product Monograph sections, though specific text was cut off at Storage and Stability). |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Metoprolol |
|---|---|
| ATC code | C07AB02 |
| AHFS class | 24:24.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02315122 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2315122 |
| Brand name | METOPROLOL-L |
| Generic / active ingredient | METOPROLOL TARTRATE : 100 MG |
| Market authorization holder | SORRES PHARMA INC |
| Health Canada schedule | Prescription |
| ATC code | C07AB02 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C07AB |
| Current status | CANCELLED POST MARKET |
| Status date | 20-Jun-2014 |
| Original market date | 2009-02-26 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Hypertension: 100-200mg daily. Angina: 100-400mg daily in divided doses. Myocardial Infarction: Maintenance 100mg twice daily. Administer with or immediately following meals.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to metoprolol; sinus bradycardia; sick sinus syndrome; 2nd/3rd degree A-V block; overt heart failure; cardiogenic shock; severe peripheral arterial disorders; untreated pheochromocytoma.
Warnings and precautions
Avoid abrupt withdrawal. May mask hypoglycemia in diabetics or hyperthyroidism signs. Use caution in patients with heart failure, bronchospastic disease, or peripheral vascular disease.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
30 of 103 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AA-METOPROLOL SR | 100 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | 02285169 |
| APO-METOPROLOL | 25 MG | TABLET | APOTEX INC | MARKETED | 02246010 |
| APO-METOPROLOL | 50 MG | TABLET | APOTEX INC | MARKETED | 00618632 |
| APO-METOPROLOL | 100 MG | TABLET | APOTEX INC | MARKETED | 00618640 |
| APO-METOPROLOL (TYPE L) | 50 MG | TABLET | APOTEX INC | MARKETED | 00749354 |
| APO-METOPROLOL (TYPE L) | 100 MG | TABLET | APOTEX INC | MARKETED | 00751170 |
| JAMP-METOPROLOL-L | 25 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02356813 |
| JAMP-METOPROLOL-L | 50 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02356821 |
| JAMP-METOPROLOL-L | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02356848 |
| METOPROLOL | 50 MG | TABLET | SANIS HEALTH INC | MARKETED | 02350394 |
2 · Same class — other molecules in ATC C07AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Metoprolol | AA-METOPROLOL SR · AG-METOPROLOL-L · APO-METOPROLOL · APO-METOPROLOL (TYPE L) · +44 more | 103 | 30 | Yes |
| Atenolol | ACT ATENOLOL · AG-ATENOLOL · APO-ATENOL TAB 100MG · APO-ATENOL TAB 50MG · +35 more | 87 | 28 | Yes |
| Bisoprolol | AG-BISOPROLOL · APO-BISOPROLOL · AVA-BISOPROLOL · BISOPROLOL · +19 more | 52 | 24 | Yes |
| Nebivolol | APO-NEBIVOLOL · BYSTOLIC · JAMP NEBIVOLOL · PRZ-NEBIVOLOL | 13 | 9 | Yes |
| Acebutolol | ACEBUTOLOL · ACEBUTOLOL - 400 · ACEBUTOLOL-100 · ACEBUTOLOL-200 · +20 more | 44 | 6 | Yes |
| Esmolol | BREVIBLOC INJECTION 10MG/ML · BREVIBLOC INJECTION 250MG/ML · BREVIBLOC LIQ IV 10MG/ML · BREVIBLOC LIQ IV 250MG/ML · +1 more | 5 | 2 | Yes |
| Landiolol | SIBBORAN | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC C07A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| C07AG | Carvedilol · Labetalol | 99 | 38 |
| C07AA | Nadolol · Oxprenolol · Pindolol · Propranolol · Sotalol · +1 more | 177 | 27 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is METOPROLOL-L called?
The same molecule, Metoprolol, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| BETALOC ZOK | Latin | Czechia |
| EGILOK | Latin | Czechia |
| HYPABLO | Latin | Czechia |
| BLOXAZOC | Latin | Czechia |
| BETALOC SR | Latin | Czechia |
| METOPROLOL MEDREG | Latin | Czechia |
| BETALOC | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Metoprolol called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Metoprolol, published to help those searches reach this page.
| Language | Metoprolol |
|---|---|
| Arabic العربية | ميتوبرولول |
| Chinese (Simplified) 简体中文 | 美托洛尔 |
| Russian Русский | Метопролол |
| Spanish Español | Metoprolol |
| Portuguese Português | Metoprolol |
| German Deutsch | Metoprolol |
| Japanese 日本語 | メトプロロール |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.